EnglishУкраїнська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    Khodakovskiy O.A., Zhaboiedova N.V., Rokunets I.L. Zagorii G.V.

    COMPERTIVE ESTIMATION OF INFLUENCE OF ADEMOL AND NIMODIPINE


    About the author: Khodakovskiy O.A., Zhaboiedova N.V., Rokunets I.L. Zagorii G.V.
    Heading EXPERIMENTAL MEDICINE
    Type of article Scentific article
    Annotation In experiments on the rats with model of intracerebral hemorrhage of middle level of heaviness (introduction of own blood in subarachnoid space of 0.1 ml/100 g) was seen twice reduction of blood circulation in region of internal carotid artery in first 96 hours after modeling of pathology. Experimental Therapy industrial design ampoule 1.0% solution of 1-adamantyletyloksy-3-morpholino-2-propanol hydrochloride ("Ademol-Darnitsa" Darnitsa, Ukraine), relatively effective dose of 2 mg / kg intravenously every 24 hours for 4 days model of hemorrhagic stroke, similar to nimodipine (30 mkg/kg) prevented the decrease in cerebral hemodynamics. Thus, at the end of the experiment on the background of the introduction of "Ademol" indicator cortical volumetric flow rate remained higher relative to control group of animals Pathology average of 30.5%. Stimulatory effect "Ademol" on blood flow in the cerebral cortex, is an important part of its neuroprotective action in hemorrhagic stroke. Given that the study drug than stimulating effect on cerebral hemodynamics, as a modulator of NMDA-receptor activity - is promising further in-depth preclinical evaluation of its effectiveness in the treatment of stroke.
    Tags «Ademol», intracerebral hemorrhage, nimodipine
    Bibliography
    • Zhaboyedova N. V. Skrining tserebroprotektornih vlastivostey promislovogo zrazka ampulnogo rozchinu 1-adamantiletiloksi-3-morfolino-2-propanolu gidrohloridu («Ademol») na modelyah gostrogo porushennya mozkovogo krovoobIgu za gemoragIchnim tipom / N. V. Zhaboyedova, G. V. Zagoriy, O. A. Hodakivskiy // Visnik morfologiyi. – 2016, T. 22, No. 1. – S. 71-77.
    • Hodakivskiy O. A. Patogenetichne obgruntuvannya dotsilnosti vikoristannya novih pohidnih adamant anu pri eksperimentalniy terapiyi gostroyi ishemiyi golovnogo mozku ta miokarda (eksperimentalne doslidzhennya) : avtoref. dis. d. med. n. : spets. 14.03.05 – farmakologiya / O. A. Hodakivskiy. – Odesa., -2014. – 24 s.
    • Hodakivskiy O. A. Harakteristika protiishemichnih ta mnemotropnih vlastivostey ademolu pri modelnomu gostromu porushenni mozkovogo krovoobigu / O. A. Hodakivskiy // Fiziologichniy zhurnal. – 2013. – T. 59, No. 5. – S. 71-77.
    • Chekman I. S. Doklinicheskoe izuchenie spetsificheskoy aktivnosti potentsialnyih neyroprotektivnyih preparatov: metod. Rekomendatsii / I. S. Chekman, Yu. I. Gubskiy, I. F. Belenichev [i dr.]. – Kiev, -2010. – 81 s.
    • Yarosh O. K. Metod vidtvorennya intratserebralnoyigemoragiyi u bilih schuriv / O. K. Yarosh, S. V.Kirichenko, S. P. Halimonchik [ta in.] // Krovoobig ta gemostaz. – 2005. – No. 1. – S. 77-81.
    • Connolly E. S. Jr.Guidelines for themanagement of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association / american Stroke Association. / E. S. Jr.Connolly, A. A. Rabinstein, J. R Carhuapoma [et al.] // Stroke. – 2012. – Vol. 43. – Р. 1711-1737.
    • Morgenstern L. B. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association / L. B. Morgenstern, J. C. Hemphill 3rd, C.Anderson Carhuapoma [et al.] // Stroke. – 2010. – Vol. 41. – Р. 2108-2129.
    Publication of the article «World of Medicine and Biology» №3(57), 2016 year, 150-153 pages, index UDK 616.831-005.1:615.015:615.21:612.13